Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders

NCT00801931 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Poor accrual

Conditions

Leukemia
Lymphoma
Neuroblastoma
Immunodeficiencies
Anemia

Interventions

DRUG: Alemtuzumab
RADIATION: Total Body Irradiation
DRUG: Melphalan
DRUG: Busulfan
DRUG: Phenytoin
DRUG: Fludarabine
DRUG: Cyclophosphamide
DRUG: Horse Antithymocyte Globulin
DRUG: Rabbit Antithymocyte Globulin
DRUG: Thiotepa

Sponsor

Columbia University